h2 {
text-align: center;
}
.section {
margin-bottom: 20px;
}
.section-title {
font-weight: bold;
margin-bottom: 10px;
}
ul {
list-style-type: disc;
margin-left: 20px;
}
li {
margin-bottom: 5px;
}
.disclaimer {
font-style: italic;
text-align: center;
}
Monocaps Capsules 20mg: Effective Relief for Angina Pectoris
Description:
Monocaps capsules contain 20mg of isosorbide mononitrate, a powerful vasodilator that primarily targets venous vessels, offering effective relief for angina pectoris.
Key Benefits:
- Reduces Angina Attacks: Monocaps effectively prevents and alleviates angina episodes by widening blood vessels, improving blood flow to the heart, and reducing oxygen demand.
- Improves Heart Function: It helps manage chronic heart failure, some forms of pulmonary hypertension, and cor pulmonale by reducing strain on the heart and improving circulation.
- Safe and Effective: Monocaps has been clinically proven to be a safe and effective treatment option for angina pectoris, with minimal side effects when used as prescribed.
Important Information:
- Dosage: Monocaps capsules are taken orally after meals, typically 20-40 mg per dose 2-3 times a day, with an interval of 7-8 hours.
- Duration of Treatment: The frequency of administration and duration of treatment are determined individually by a healthcare professional.
- Potential Side Effects: Common side effects include headaches, dizziness, flushing, and a decrease in blood pressure. It is important to consult with your doctor if you experience any unusual or persistent side effects.
- Interactions: Monocaps may interact with other medications, including vasodilators, antihypertensives, beta-blockers, and other heart medications. It is essential to inform your doctor about all medications and supplements you are taking before starting Monocaps treatment.
- Contraindications: Monocaps is not suitable for everyone. It should not be used by individuals with certain medical conditions, including acute circulatory disorders, severe arterial hypotension, cardiogenic shock, hemorrhagic stroke, and hypersensitivity to nitrates.
Disclaimer:
This information is not intended as a substitute for professional medical advice. Always consult with your healthcare provider before starting any new medication, including Monocaps.
Find out more about Monocaps and its availability by contacting your local pharmacy or healthcare provider.
Keywords:
Angina Pectoris, Isosorbide Mononitrate, Vasodilator, Venous Vessels, Antianginal, Heart Disease, Chronic Heart Failure, Pulmonary Hypertension, Cor Pulmonale, Monocaps, Capsules, 20mg, Medication, Treatment, Relief, Side Effects, Interactions, Contraindications, Dosage, Pharmacy, Healthcare Provider.
| INN | ISOSORBIDE MONONITRATE |
|---|---|
| The code | 18 114 |
| Barcode | 4 810 046 002 472 |
| Dosage | 20mg |
| Active substance | Isosorbide mononitrate |
| Manufacturer | Minskintercaps UP RB, Belarus |
| Indications Applications | Monocaps is indicated for the prevention of angina attacks in the post-infarction period. It is used as part of combination therapy in the treatment of chronic heart failure, some forms of pulmonary hypertension and cor pulmonale. |
| Contraindications | hypersensitivity to the drug and other organic nitrates; acute circulatory disorders (shock, vascular collapse); cardiogenic shock, if correction of the end diastolic pressure of the left ventricle is impossible with the help of intra-aortic counterpulsation or due to the introduction of agents that have a positive inotropic effect; hemorrhagic stroke; acute myocardial infarction with reduced filling pressure of the left ventricle; severe arterial hypotension (systolic blood pressure less than 90 mm Hg, and diastolic blood pressure less than 60 mm Hg, central venous pressure below 4-5 mm Hg), hypovolemia; simultaneous administration of phosphodiesterase inhibitors, including sildenafil, vardenafil, tadalafil, as they potentiate the hypotensive effect of the drug; acute myocardial infarction with severe arterial hypotension; anemia (severe); hereditary galactose intolerance, lactase deficiency or malabsorption syndrome of glucose and galactose; toxic pulmonary edema; lactation period; age up to 18 years (efficacy and safety have not been established). Use with caution in hypertrophic obstructive cardiomyopathy, constrictive pericarditis, pericardial tamponade; with reduced filling pressure of the left ventricle, for example, with acute myocardial infarction (risk of lowering blood pressure and tachycardia, which can increase ischemia), a decrease in left ventricular function (left ventricular failure). Systolic blood pressure should not be allowed to fall below 90 mm Hg; with aortic and / or mitral stenosis; with a tendency to arterial hypotension (orthostatic disturbances in the regulation of blood circulation); in heart failure with low filling pressure of the left ventricle; with glaucoma (risk of increased intraocular pressure); in diseases accompanied by an increase in intracranial pressure (previously, an increase in pressure was noted only with intravenous administration of high doses of nitroglycerin), including with hemorrhagic stroke, a recent head injury; with severe anemia; with severe renal failure; with liver failure (risk of developing methemoglobinemia). |
| Side effects | From the side of the cardiovascular system: at the beginning of treatment, a headache ("nitrate" headache) may occur, which usually decreases after a few days of therapy; dizziness, flushing of the skin of the face, feeling of heat, tachycardia. Sometimes at the first dose of the drug or after increasing the dose, a decrease in blood pressure and / or orthostatic hypotension is observed, which may be accompanied by a reflex increase in heart rate, lethargy, as well as dizziness and a feeling of weakness. In rare cases, increased angina attacks (paradoxical reaction to nitrates), orthostatic collapse. There have been cases of collaptoid states, sometimes with bradyarrhythmia and syncope. From the gastrointestinal tract: nausea, vomiting, there may be a slight burning sensation of the tongue, dry mouth. From the side of the central nervous system: stiffness, drowsiness, blurred vision, decreased ability to quick mental and motor reactions (especially at the beginning of treatment). In rare cases, cerebral ischemia. Allergic reactions: skin rash, in some cases – exfoliative dermatitis. Other: development of tolerance (including cross to other nitrates). To prevent the development of tolerance, continuous high doses of the drug should be avoided. In some cases, exfoliative dermatitis (severe cases of exudative erythema multiforme, widespread impetigo and toxicoderma). The use of Monocaps can lead to transient hypoxemia due to the relative redistribution of blood flow to hypoventilated alveolar segments. This may be a trigger for ischemia in patients with coronary heart disease. |
| Use during pregnancy and lactation | unknown |
| Age category | 18+ |
| Application Gender | Any |
| Release Form | Capsules |
| Main Active Substances | Isosorbide mononitrate 20 mg. |
| Composition Means | Isosorbide mononitrate 20 mg. |
Related products
